Hepatitis B Vaccine Response

Single cell RNA sequencing (scRNAseq) provides a powerful tool to explore the cellular diversity of complex biological samples. We have used scRNAseq to explore the innate immune cell response (monocytes, NKs, mDCs, pDCs, neutrophils) to a single dose of the Hepatitis B vaccine to determine if any cellular signatures might correlate with vaccine responses. Clustering of the scRNAseq transcriptional profiles identified two mDC subsets with differential representation pre- and post-vaccination.

Although the numbers are small, Day 0 samples that had a relatively high proportion of the minor mDC subtype, the NDRG2-expressing mDCs, generated anti-HepB serum antibodies in response to a single vaccination dose, whereas Day 0 samples that had relatively low proportions did not. These preliminary results suggest that the relative proportions of mDC subtypes in peripheral blood may be a predictor of vaccine responses and raise the possibility that pre-conditioning patients to increase the relative proportion of NDRG2-expressing mDCs may be an effective strategy to boost vaccine efficacy.


This work is funded by the Human Vaccines Project.

Principal Investigator

Key Staff

  • Brian Aevermann, MS
  • Mark Novotny


Tobi Kollmann, Manish Sadarangani, Rym Ben-Othman, Cai Bing, and Aaron Liu
University of British Columbia

Related Research